MEDICINES CO /DE Patent Applications Rejected
1 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2017-10-18: Application 15787405; Invention Methods for Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Protein Reduction; Applicant The Medicines Company; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2017-10-18 | 15787405 | Methods for Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Protein Reduction | The Medicines Company | Abandoned -- Failure to Respond to an Office Action | US20180104360A1 | Peter Wijngaard David Kallend | United States Switzerland | GIBBS, TERRA C |